Showcases Exosome-Based Veterinary Medical Device “ReproPet”STEMON took part in Pet Fair Asia in Shanghai, one of the world’s largest exhibitions for companion animals, where it showcased its exosome-based veterinary medical device “ReproPet.”ReproPet applies exosome technology to support regenerative treatment and health recovery for pets, offering an advanced solution in the veterinary field. The product drew significant interest from industry experts and buyers during the exhibition. STEMON stated that it will leverage this event to further raise awareness of its technological competitiveness in animal healthcare and accelerate its expansion into global markets.

Launches Two New Exosome-Based Products with Filler Ingredients, Attracting Strong InterestSTEMON participated in the beauty exhibition In-Cosmetics Korea, unveiling two innovative new products that incorporate filler ingredients into exosomes.The launch drew significant attention from visitors and industry professionals alike. The newly introduced products stand out as advanced solutions for skin regeneration and improved elasticity, offering a scientific approach that differentiates them from conventional skincare. The exhibition generated active discussions with buyers and experts, who responded positively to the company’s technology. STEMON announced that it will leverage this exhibition as a stepping stone to strengthen its presence in both domestic and international markets, while further solidifying its technological competitiveness in the global beauty industry.

Draws Strong Interest and Positive Response from InvestorsSTEMON took part in the global startup fair NextRise 2025, where it showcased its innovative exosome-based skin regeneration technology, attracting significant attention and positive feedback from investors and industry professionals. During the exhibition, STEMON highlighted the differentiated competitiveness of its next-generation skin regeneration solutionsand presented its growth potential and business vision for the global market. Many investors expressed strong interest in the company’s technology and market prospects,leading to active discussions on potential collaborations. STEMON announced that it will leverage this event as an opportunity to expand its global network and accelerate entry into overseas markets through strategic partnerships.

StemOn has been selected as a finalist in the research and innovation category of L'Oréal's open innovation program, "L'Oréal BIG BANG"through the "K-Startup X France Meetup Day" jointly hosted by the Ministry of SMEs and Startups and L'Oréal Korea.The company was chosen for the program in recognition of the innovativeness of its digital cell reprogramming technology-based personalized functional cosmetic ingredients.Through this program, StemOn is expected to receive various forms of support, including opportunities for technological collaboration with L'Oréal’s global brand team, as well as mentoring, consulting, marketing, and networking.In addition, the company plans to receive up to 200 million KRW in commercialization funding and a customized specialized program from the Ministry of SMEs and Startups.

STEMON participated in the 2025 China Beauty Expo (CBE 2025), held from May 12 to 14 in Shanghai, where it showcased its cutting-edge exosome-based skin regeneration technology. Unlike conventional skincare, STEMON’s approach leverages a scientific method that promotes regeneration at the cellular level, drawing strong interest from industry professionals. The company’s solution, particularly effective in skin recovery and anti-aging, received notable attention. STEMON aims to leverage this exhibition to strengthen its technological competitiveness and brand presence across China and the broader Asian market. Meanwhile, CEO Soonhak Kim successfully delivered a presentation on the company’s technology during the “Korea Pavilion New Product Launch – Beauty Day” event on May 13.

STEMON participated in DUBAI DERMA 2025, held in Dubai, UAE, from April 14 to 16, 2025, where it unveiled its advanced exosome-based technologies and skin regeneration solutions. During the exhibition, STEMON introduced a range of skincare products featuring its exosome technology, known for its effectiveness in skin repair and anti-aging, drawing significant attention from professionals in the medical and aesthetic fields as well as from visitors. Through this exhibition, STEMON aims to expand its presence in the global beauty market, including the Middle East, and actively pursue new partnership opportunities with local distributors and specialized clinics.

STEMON participated in COSME TECH TOKYO 2025, held from January 15 to 17, 2025, in Tokyo, Japan, where it presented its latest exosome technology and innovative beauty and skincare products. At the event, STEMON introduced exosome technology designed to enhance skin health and regeneration, drawing significant interest from industry experts and visitors. The company also showcased a variety of new beauty and skincare products, receiving positive feedback for their innovation. Through this exhibition, STEMON aims to expand its presence in the Japanese market and explore new partnership opportunities globally.

STEMON participated in Cosmoprof India 2024, held from December 5 to 7, 2024, in Mumbai, showcasing its groundbreaking exosome technology for the beauty and skincare industry. At the event, STEMON presented exosome-based solutions designed to enhance skin health and support regeneration, introducing new possibilities in the Indian market. Industry experts and visitors expressed significant interest in STEMON’s exosome technology and praised its innovative potential. As a leading innovator in the global beauty industry, STEMON looks forward to fostering new partnerships, including in the Indian market, through this event.